Alteral Therapeutics ApS
SEC insider (Form 3/4/5 filer). CIK 0002026040. 10% Owner at Nordicus Partners Corp (NORD). 1 reported Form 4/5 transaction since Sep 2024; latest on Nov 12, 2024. Located in KLAMPENBORG, G7.
Companies Alteral Therapeutics ApS has filed insider reports for
- Nordicus Partners Corp (NORD): 10% Owner
Alteral Therapeutics ApS
CIK: 0002026040
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NORD
Nordicus Partners Corp
10% Owner